SSKN
SSKN
NASDAQ · Health Care

Strata Skin Sciences Inc

$0.00
+0.00 (+0.00%)
Financial Highlights (FY 2026)
Revenue
38.88M
Net Income
-7,929,707
Gross Margin
58.2%
Profit Margin
-20.4%
Rev Growth
-5.3%
D/E Ratio
5.37
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 58.2% 58.2% 60.4% 60.4%
Operating Margin -15.3% -13.8% 8.3% 6.6%
Profit Margin -20.4% -19.4% 6.1% 6.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 38.88M 41.06M 4.50M 3.54M
Gross Profit 22.65M 23.92M 2.72M 2.14M
Operating Income -5,952,060 -5,657,254 373.5K 235.6K
Net Income -7,929,707 -7,536,948 275.7K 228.3K
Gross Margin 58.2% 58.2% 60.4% 60.4%
Operating Margin -15.3% -13.8% 8.3% 6.6%
Profit Margin -20.4% -19.4% 6.1% 6.4%
Rev Growth -5.3% -5.3% +8.7% -6.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 247 247 2.50M 2.27M
Total Equity 46 46 2.00M 2.12M
D/E Ratio 5.37 5.37 1.25 1.07
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -730,949 -733,342 439.3K 404.4K
Free Cash Flow — — 280.3K 178.6K